Cleared Traditional

PARALLELING GUIDES (K914715) - FDA 510(k) Clearance

Class I General & Plastic Surgery device.

K914715 · Implant Corp. of America · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1994
Decision
852d
Days
Class 1
Risk

K914715 is an FDA 510(k) clearance for the PARALLELING GUIDES. Classified as Guide, Surgical, Instrument (product code FZX), Class I - General Controls.

Submitted by Implant Corp. of America (St. Petersburg, US). The FDA issued a Cleared decision on February 16, 1994 after a review of 852 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4800 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind General & Plastic Surgery submissions.

View all Implant Corp. of America devices

Submission Details

510(k) Number K914715 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 18, 1991
Decision Date February 16, 1994
Days to Decision 852 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
737d slower than avg
Panel avg: 115d · This submission: 852d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code FZX Guide, Surgical, Instrument
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 878.4800
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.